REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
16/05/2026
Voltar para busca
Dado oficial do USPTO
SEE MORE. TREAT SMARTER.
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SEE MORE. TREAT SMARTER.
ST13
US500000086764515Classe
5, 10, 41
Pedido
86764515
Registro
5205582
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
17/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 41
Data de depósito
22/09/2015
Data de registro
16/05/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/05/2025
Última transação
17/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
23/12/2015
Primeiro uso no comércio
23/12/2015
Código do desenho
4
Tipo de titular
99
Localização do titular
London, GB
Examinador
BROOKSHIRE, DAVID AARON
Localização atual
Historical data usage
Titulares e representantes
Titulares
BTG International Limited
Representantes
Lori A. Ruhly Quarles & Brady LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 41
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalmedicinal substancespharmaceutical preparations for the treatment of cancerpharmaceutical preparations and substances for the treatment of thrombosisembolismsdrug delivery agentspreparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substancesdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolisation; pharmaceutical preparations and substances for embolisation of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; transarterial chemoembolisation pharmaceutical preparations ; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substancestherapeutic agents for delivery of radioactive materials to target sites within the body for the treatment of cancer
Classe 10
Surgicalmedical apparatus and instrumentsmedical deviceapparatus and instruments for treating cancer; drug delivery embolisation apparatusinstruments and systems; apparatus and instruments for use in the circulatory systemcathetersinjection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instrumentscathetersinjection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatusinstruments and systems comprising surgical and medical instruments for embolizationembolic devices for use in treating cancer and tumorsembolic devices for treating arteriovenous malformations (AVMs) of the bodyembolic devices for use in treating tumors; drug delivery embolisation systems; drug delivery apparatus and instruments namelya drug delivery system comprised of injection syringes and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory systemcathetersinjection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; medical apparatus and instruments for embolizationmedical devices in the nature of particlesembolic microspheres for embolization ; surgical and medical apparatus and instruments for embolisationembolisation apparatusinstruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments for use in the circulatory system; surgical and medical apparatus for use in treatment ofarterio-venous malformations; syringes for use in treatment ofarterio-venous malformations
Classe 41
Educationdevelopingarranging and conducting educational seminarsworkshops and programs and providing courses of instruction in the fields of healthcarethe use of pharmaceuticals and medical devicesmedical researchsurgerymedical sciencemedicinemedical diseasesdisorders and related treatments; provision of educational content namelyproviding on-line instruction in the fields of healthcarethe use of pharmaceuticals and medical devicesmedical researchsurgerymedical sciencemedicinemedical diseasesdisorders and related treatments; providing computerelectronic and online databases featuring information about medical education in the field of healthcaremedicinemedical treatment and patient care; training in the use and operation of pharmaceutical productspharmaceutical preparationsradiopharmaceutical preparationsmedical devicesmedical imaging apparatus and medical research apparatus and consultation relating thereto; educational servicesconducting live and online seminarsclassesworkshopslecturespanel discussionstraining programs in the fields of healthcarethe use of pharmaceutical and medical devicesmedical researchsurgerymedical sciencemedicine and medical diseasesdisorders and related treatments; Educational servicesproviding non-downloadable webinars in the fields of healthcarethe use of pharmaceuticals and medical devicesmedical researchsurgerymedical sciencemedicinemedical diseasesdisorders and related treatments; educational servicesconducting live and online seminarsclassesworkshopslecturespanel discussions and training in the field of health; educational servicesproviding non-downloadable webinars in the field of health; education servicesconducting online and telephonic instruction and courses in the fields of health and medical issues
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
15/05/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
15/05/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/10/2024
XXXX
POST REGISTRATION ACTION CORRECTION
09/10/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/10/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/10/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/10/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/10/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
21/05/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/05/2024
E815
TEAS SECTION 8 & 15 RECEIVED
16/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/03/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/03/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
16/05/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/08/2020
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
29/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/08/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
16/05/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/04/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/04/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
17/03/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
16/03/2017
IUAF
USE AMENDMENT FILED
06/03/2017
EISU
TEAS STATEMENT OF USE RECEIVED
06/03/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/09/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2016
PUBO
PUBLISHED FOR OPPOSITION
12/07/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/06/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
02/06/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/06/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
02/06/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/06/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/05/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/05/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/05/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/01/2016
GNRT
NON-FINAL ACTION E-MAILED
09/01/2016
CNRT
NON-FINAL ACTION WRITTEN
09/01/2016
DOCK
ASSIGNED TO EXAMINER
09/01/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/09/2015
NWAP
NEW APPLICATION ENTERED
25/09/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SEE MORE. TREAT SMARTER. ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.